Exogenous Toxicants and Genetic Susceptibility in ALS
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00011154 |
Recruitment Status :
Completed
First Posted : February 14, 2001
Last Update Posted : March 23, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Amyotrophic Lateral Sclerosis |
Study Type : | Observational |
Enrollment : | 525 participants |
Observational Model: | Defined Population |
Time Perspective: | Other |
Study Start Date : | September 1996 |
Study Completion Date : | August 2002 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Individuals with ALS within the Kaiser Permanente population of Northern California, ages 18 years and older, with first diagnosis of ALS in the years 1996-2000.
Controls are individuals who are age- and sex-matched to the patients with ALS, also from the Kaiser Permanente population.
ClinicalTrials.gov Identifier: | NCT00011154 |
Other Study ID Numbers: |
8150-CP-001 |
First Posted: | February 14, 2001 Key Record Dates |
Last Update Posted: | March 23, 2006 |
Last Verified: | March 2006 |
Motor Neuron Disease Amyotrophic Lateral Sclerosis Neurodegenerative Diseases Nervous System Diseases Neuromuscular Diseases |
Spinal Cord Diseases Central Nervous System Diseases TDP-43 Proteinopathies Proteostasis Deficiencies Metabolic Diseases |